Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A common anesthesiology procedure for a patient with an uncommon combination of diseases: a case report.
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
[Optical coherence tomography in neuro-ophthalmology].
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
Place of perineal electrophysiologic testing in multiple sclerosis patients.
Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort.
Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Transglutaminase 2 and neuroinflammation.
cFLIP is critical for oligodendrocyte protection from inflammation.
[Current description of multiple sclerosis].
Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients.
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
γδ T cells as early sensors of tissue damage and mediators of secondary neurodegeneration.
Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC.
T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients.
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS.
A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
Cladribine in multiple sclerosis: pitfalls in a new treatment landscape.
Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.
A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice.
Pages
« first
‹ previous
…
360
361
362
363
364
365
366
367
368
…
next ›
last »